|
| 37296356 | The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future Perspectives. | Neurotherapeutics | 2023 |
| 37206223 | Galactosylated hydroxyl-polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning-induced liver failure. | Bioeng Transl Med | 2023 |
| 34260042 | Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis. | Neurotherapeutics | 2021 |
| 33902708 | Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease. | Acta Neuropathol Commun | 2021 |
| 34854297 | Correction to "A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease". | J Med Chem | 2021 |
| 34673570 | Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy. | JCI Insight | 2021 |
| 34583507 | A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease. | J Med Chem | 2021 |
| 34324818 | Rationally Designed Galactose Dendrimer for Hepatocyte-Specific Targeting and Intracellular Drug Delivery for the Treatment of Liver Disorders. | Biomacromolecules | 2021 |
| 32901093 | Tyrosine kinase inhibitor neratinib attenuates liver fibrosis by targeting activated hepatic stellate cells. | Sci Rep | 2020 |
| 32829570 | Inhibition of PI3K/Akt signaling suppresses epithelial-to-mesenchymal transition in hepatocellular carcinoma through the Snail/GSK-3/beta-catenin pathway. | Clin Mol Hepatol | 2020 |
| 32822742 | Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats. | J Control Release | 2020 |
| 30875759 | Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma. | Int J Mol Sci | 2019 |
| 31653035 | Quercetin Synergistically Inhibit EBV-Associated Gastric Carcinoma with <i>Ganoderma lucidum</i> Extracts. | Molecules | 2019 |
| 30850660 | Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma. | Nat Commun | 2019 |
| 29668411 | Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential. | Radiology | 2018 |
| 29892066 | Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease. | Nat Med | 2018 |
| 30106087 | Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK. | Int J Mol Med | 2018 |
| 29805610 | Transforming growth factor-β decreases side population cells in hepatocellular carcinoma <i>in vitro</i>. | Oncol Lett | 2018 |
| 29964331 | Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. | Mol Carcinog | 2018 |
| 29988049 | Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease. | Nat Nanotechnol | 2018 |
| 29897434 | The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model. | Hum Mol Genet | 2018 |
| 28049449 | Association of atopic dermatitis with depressive symptoms and suicidal behaviors among adolescents in Korea: the 2013 Korean Youth Risk Behavior Survey. | BMC Psychiatry | 2017 |
| 28258480 | The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells. | Arch Pharm Res | 2017 |
| 28362858 | 3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells. | PLoS One | 2017 |
| 28957709 | Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo. | Biomaterials | 2017 |
| 29017854 | PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells. | J Control Release | 2017 |
| 28582715 | In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface. | Biomaterials | 2017 |
| 26996446 | ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer. | Sci Rep | 2016 |
| 26639578 | Polysaccharide-based nanoparticles for theranostic nanomedicine. | Adv Drug Deliv Rev | 2016 |
| 27762044 | Cathepsinâ¿¿B-Specific Metabolic Precursor for Inâ¿¿Vivo Tumor-Specific Fluorescence Imaging. | Angew Chem Int Ed Engl | 2016 |
| 27654060 | Precise Targeting of Liver Tumor Using Glycol Chitosan Nanoparticles: Mechanisms, Key Factors, and Their Implications. | Mol Pharm | 2016 |
| 27681719 | Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma. | Molecules | 2016 |
| 27091428 | 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. | Biochem Biophys Res Commun | 2016 |
| 26710118 | Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. | Hepatology | 2016 |
| 26680637 | Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain. | Small | 2016 |
| 26930274 | Bioorthogonal Copper Free Click Chemistry for Labeling and Tracking of Chondrocytes In Vivo. | Bioconjug Chem | 2016 |
| 27113247 | T1-Weighted MR imaging of liver tumor by gadolinium-encapsulated glycol chitosan nanoparticles without non-specific toxicity in normal tissues. | Nanoscale | 2016 |
| 24255545 | Inhibition of notch signalling ameliorates experimental inflammatory arthritis. | Ann Rheum Dis | 2015 |
| 26460271 | Sorafenib inhibits cancer side population cells by targeting câ¿¿Jun Nâ¿¿terminal kinase signaling. | Mol Med Rep | 2015 |
| 26381901 | Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors. | J Control Release | 2015 |
| 26583759 | What is the future of PEGylated therapies? | Expert Opin Emerg Drugs | 2015 |
| 26284086 | Functional analysis of the BRI1 receptor kinase by Thr-for-Ser substitution in a regulatory autophosphorylation site. | Front Plant Sci | 2015 |
| 26307351 | Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo. | J Control Release | 2015 |
| 26681985 | Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics. | Theranostics | 2015 |
| 26115996 | Anti-tumor effect of Cordyceps militaris in HCV-infected human hepatocarcinoma 7.5 cells. | J Microbiol | 2015 |
| 26141646 | Anti-cancer effect of Cordyceps militaris in human colorectal carcinoma RKO cells via cell cycle arrest and mitochondrial apoptosis. | Daru | 2015 |
| 25761435 | Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain. | Adv Healthc Mater | 2015 |
| 24266806 | Rational design of matrix metalloproteinase-13 activatable probes for enhanced specificity. | ACS Chem Biol | 2014 |
| 25363213 | Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA. | Sci Rep | 2014 |
| 25033207 | A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo. | Nat Protoc | 2014 |